Delpha Capital Management’s CONMED CNMD Stock Holding History

Delpha Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-74	Closed	-$4K	–	334
2017 Q4	$4K	Buy	+74	New	+$3.85K	﹤0.01%	1330

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Delpha Capital Management's CNMD Position: Q1 2018 in Review

Delpha Capital Management sold out of CONMED (CNMD) in Q1 2018, closing a stake of 74 shares — an estimated $4K sold.

Delpha Capital Management first reported a position in CNMD in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2018.

Delpha Capital Management reported no remaining CONMED position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 74 CONMED shares in Q1 2018, an estimated $4K.
Delpha Capital Management first reported a position in CONMED in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's CONMED position peaked at $4K in Q4 2017.
173 funds tracked by Wall St. Rank held CONMED as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.